pX330A_D10A-1x2 Citations (5)

Originally described in: Multiplex genome engineering in human cells using all-in-one CRISPR/Cas9 vector system.
Sakuma T, Nishikawa A, Kume S, Chayama K, Yamamoto T Sci Rep. 2014 Jun 23;4:5400. doi: 10.1038/srep05400. PubMed Journal

---

Articles Citing pX330A_D10A-1x2

Articles
Engineering of Systematic Elimination of a Targeted Chromosome in Human Cells. Sato H, Kato H, Yamaza H, Masuda K, Nguyen HT, Pham TT, Han X, Hirofuji Y, Nonaka K. Biomed Res Int. 2017;2017:6037159. doi: 10.1155/2017/6037159. Epub 2017 Mar 19. PubMed
A conserved enhancer regulates Il9 expression in multiple lineages. Koh B, Abdul Qayum A, Srivastava R, Fu Y, Ulrich BJ, Janga SC, Kaplan MH. Nat Commun. 2018 Nov 15;9(1):4803. doi: 10.1038/s41467-018-07202-0. PubMed
STAT5 promotes accessibility and is required for BATF-mediated plasticity at the Il9 locus. Fu Y, Wang J, Panangipalli G, Ulrich BJ, Koh B, Xu C, Kharwadkar R, Chu X, Wang Y, Gao H, Wu W, Sun J, Tepper RS, Zhou B, Janga SC, Yang K, Kaplan MH. Nat Commun. 2020 Sep 28;11(1):4882. doi: 10.1038/s41467-020-18648-6. PubMed
Nance-Horan Syndrome-like 1 protein negatively regulates Scar/WAVE-Arp2/3 activity and inhibits lamellipodia stability and cell migration. Law AL, Jalal S, Pallett T, Mosis F, Guni A, Brayford S, Yolland L, Marcotti S, Levitt JA, Poland SP, Rowe-Sampson M, Jandke A, Kochl R, Pula G, Ameer-Beg SM, Stramer BM, Krause M. Nat Commun. 2021 Sep 28;12(1):5687. doi: 10.1038/s41467-021-25916-6. PubMed
Protein kinase RNA-activated controls mitotic progression and determines paclitaxel chemosensitivity through B-cell lymphoma 2 in ovarian cancer. Yin L, Zeng Y, Zeng R, Chen Y, Wang TL, Rodabaugh KJ, Yu F, Natarajan A, Karpf AR, Dong J. Oncogene. 2021 Dec;40(50):6772-6785. doi: 10.1038/s41388-021-02117-5. Epub 2021 Nov 19. PubMed

If you have published an article using this material, please email us at to have your article added to this page.